alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF FIRST INDUSTRIAL, L.P. FOR THE SIX MONTHS ENDED JUNE 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           2,547
<SECURITIES>                                         0
<RECEIVABLES>                                   11,767
<ALLOWANCES>                                   (1,707)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                12,607
<PP&E>                                       2,183,318
<DEPRECIATION>                               (200,189)
<TOTAL-ASSETS>                               2,518,124
<CURRENT-LIABILITIES>                          106,363
<BONDS>                                      1,172,701
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,219,117
<TOTAL-LIABILITY-AND-EQUITY>                 2,518,124
<SALES>                                              0
<TOTAL-REVENUES>                               158,089
<CGS>                                                0
<TOTAL-COSTS>                                 (46,387)
<OTHER-EXPENSES>                              (37,929)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (38,559)
<INCOME-PRETAX>                                 65,609
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             65,609
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    65,609
<EPS-BASIC>                                       1.12
<EPS-DILUTED>                                     1.12


</TABLE>
Exhibit 99.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF
2002



I, John J. Flavio, Senior Vice President of Finance and
Chief Financial Officer of Keynote Systems, Inc. (the Company), do hereby certify, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| |  |  | the Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2003, as filed with the Securities and Exchange Commission on May 15, 2003 (the
Report), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods
presented therein.
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Date: May 15, 2003



|                                                                                              
|----------------------------------------------------------------------------------------------
|/s/    JOHN J. FLAVIO                                                                         
|John J. Flavio Senior Vice President and Chief Financial Officer (Principal Financial Officer)



A signed original of
this written statement required by Section 906 has been provided to Keynote Systems, Inc. and will be retained by it and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 86, Number 153 (Thursday, August 12, 2021)]
[Notices]
[Page 44410]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17165]


-----------------------------------------------------------------------

POSTAL SERVICE


Product Change--Priority Mail Negotiated Service Agreement

AGENCY: Postal Service<SUP>TM</SUP>.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Postal Service gives notice of filing a request with the 
Postal Regulatory Commission to add a domestic shipping services 
contract to the list of Negotiated Service Agreements in the Mail 
Classification Schedule's Competitive Products List.

DATES: Date of required notice: August 12, 2021.

FOR FURTHER INFORMATION CONTACT: Sean Robinson, 202-268-8405.

SUPPLEMENTARY INFORMATION: The United States Postal Service[supreg] 
hereby gives notice that, pursuant to 39 U.S.C. 3642 and 3632(b)(3), on 
August 2, 2021, it filed with the Postal Regulatory Commission a USPS 
Request to Add Priority Mail Contract 716 to Competitive Product List. 
Documents are available at www.prc.gov, Docket Nos. MC2021-119, CP2021-
121.

Sean Robinson,
Attorney, Corporate and Postal Business Law.
[FR Doc. 2021-17165 Filed 8-11-21; 8:45 am]
BILLING CODE 7710-12-P
Dismiss and Opinion Filed March 4, 2014 

# S

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05-13-01713-CV

IN THE MATTER OF THE MARRIAGE OF D.L.S. AND P.S. AND IN THE INTEREST OF S.S., S.S., AND S.S., MINOR CHILDREN

On Appeal from the 366th Judicial District Court Collin County, Texas Trial Court Cause No. 366-56261-2011



### MEMORANDUM OPINION Before Chief Justice Wright a nd Justices Lang-Miers and Brown Opinion by Chief Justice Wright Appellee Father has filed two motions to dism iss this appeal based on appellant Mother’s
failure to pay for the appellate record. See T EX

. R. A PP

. P. 37.3(b). Our records reflect that by
order entered January 24, 2014, Mother was directed to file, no later than February 10, 2014,
written verification that she had paid or made arrangements to pay for the record. Because
Mother represented to us in a January 21, 201 4 motion that she was not seeking to proceed
without payment of costs, we cautioned Mother in our January 24th order that failure to provide
the requested verification could result in dismissal of the a ppeal without further notice. See id.

37.3(b). To date, Mother has not provided the requested verifi cation, responded to Father’s

motion, or otherwise communicated with the Court. Moreover, the district clerk has informed us–2– that, “due to non-payment,” the record has not b een filed. Accordingly, we grant the motions and
dismiss the appeal. See id. 37.3(b), 42.3(b), (c).

131713F.P05 /Carolyn Wright/ CAROLYN WRIGHT CHIEF JUSTICE–3– 

# S

Court of Appeals Fifth District of Texas at Dallas

JUDGMENT

IN THE MATTER OF THE MARRIAGE OF D.L.S. AND P.S. AND IN THE INTEREST OF S.S., S.S., AND S.S., MINOR CHILDREN

No. 05-13-01713-CV On Appeal from the 366th Judicial District Court, Collin County, Texas Trial Court Cause No. 366-56261-2011. Opinion delivered by Chief Justice Wright. Justices Lang-Miers and Brown participating.

In accordance with this Court’s opinion of this date, we DISMISS the appeal. We ORDER that appellee Deion L. Sanders recover hi s costs, if any, of this appeal from appellant Pilar Sanders.

Judgment entered March 4, 2014

/Carolyn Wright/ CAROLYN WRIGHT CHIEF JUSTICE
[Federal Register Volume 86, Number 153 (Thursday, August 12, 2021)]
[Notices]
[Page 44405]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17182]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-878]


Importer of Controlled Substances Application: Epic Pharma, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Epic Pharma, LLC. has applied to be registered as an importer 
of basic class(es) of controlled substance(s). Refer to Supplementary 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before September 13, 
2021. Such persons may also file a written request for a hearing on the 
application on or before September 13, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on July 7, 2021, Epic Pharma, LLC., 22715 North Conduit 
Avenue, Laurelton, New York 11413, applied to be registered as an 
importer of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Methadone..............................     9250  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance for 
research and development purposes.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-17182 Filed 8-11-21; 8:45 am]
BILLING CODE P
#### In the Matter of New York State Urban Development Corporation, Doing Business as Empire State Development Corporation, Respondent, Relative to Acquiring in Fee Simple Certain Real Property Currently Owned by Fallsite, LLC, and Known as: 232 Sixth Street, 700 Rainbow Blvd., 231 Sixth Street, 626 Rainbow Blvd., and 701 Falls Street, City of Niagara Falls, Situated in the County of Niagara, State of New York and Having, Respectively, the Following Tax Sections, Blocks and Lots: 159.09-2-25.122, 159.09-2-25.112, 159.09-2-25.121, 159.09-2-25.111 and 159.09-2-25.211, Together with All Compensable Interests Therein Currently Owned by Fallsite, LLC, et al., Appellants.

[942 NYS2d 914]

Appeal from an order of the Supreme Court, Niagara County (Richard C. Kloch, Sr., A.J.), entered January 24, 2011. The order, inter alia, denied respondents’ cross motion for a mistrial and recusal.

It is hereby ordered that the order so appealed from is unanimously affirmed without costs.

Memorandum: In this condemnation proceeding, respondents appeal from an order that, inter alia, denied their cross motion for a mistrial and recusal based upon Supreme Court’s alleged relationship with a partner at the law firm representing petitioner and comments made by the court in other proceedings concerning the viability of development in the Niagara Falls area. We affirm. Neither of the grounds raised in support of recusal invoke the court’s mandatory duty to recuse itself *(see*Judiciary Law § 14). Thus, recusal was a matter for the court’s discretion, and we perceive no abuse of that discretion *(see Caplash v Rochester Oral & Maxillofacial Surgery Assoc., LLC,*63 AD3d 1683, 1686 [2009]; *Matter of Gutzmer v Santini,*60 AD3d 1295 [2009], *lv dismissed*12 NY3d 889 [2009]). Present — Centra, J.P., Eeradotto, Lindley, Sconiers and Martoche, JJ.
<PAGE>

                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Silverleaf Resorts, Inc.
(the "Company") on Form 10-Q for the quarter ended March 31, 2003 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Harry J. White, Jr., Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.

Dated: May 15, 2003                                  /s/ HARRY J. WHITE, JR.
                                                  --------------------------
                                                   Harry J. White, Jr.
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Wheat Health, Genetics, and Quality Research: Pullman, WA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Pullman, Washington WHGQ People & Locations







Travis  Ruff
                        Wheat Health, Genetics, and Quality Research

                        




                        
                        Biological Science Technician (Plants)
                        Phone: (509) 335-5740
                        
                        
                        Fax: (509) 335-2553(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
**Exhibit3.2**

 

**CERTIFICATE OF AMENDMENT OF THE**

**AMENDED AND RESTATED CERTIFICATE OFINCORPORATION OF**

**PRAECIS PHARMACEUTICALS INCORPORATED**

 

Mary Beth DeLena hereby certifies that:

 

1.             She is the dulyelected and acting Secretary of PRAECIS PHARMACEUTICALS INCORPORATED, acorporation organized and existing under the laws of the state of Delaware (the“Corporation”).

 

2.             Effective at 5:00 p.m.(Delaware time) on the date of the filing of this Certificate of Amendment withthe Secretary of State of the State of Delaware (such time on such date, the “EffectiveTime”), each five (5) shares of the Corporation’s common stock, par value$.01 per share (“Common Stock), issued and outstanding immediately prior to theEffective Time shall automatically, without further action on the part of theCorporation or its stockholders, be combined into and become one (1) shareof fully paid and nonassessable Common Stock, subjectto the treatment of fractional share interests set forth below.  No fractional shares of Common Stock shall beissued by the Corporation, and the Corporation shall not recognize on its stockrecord books any purported transfer of any purported fractional shareinterest.  A holder of Common Stockimmediately prior to the Effective Time who would otherwise be entitled to afraction of a share as a result of the reverse stock split effected hereby(which shall be determined on the basis of the total number of shares of CommonStock held by a holder of record immediately prior to the Effective Time)shall, in lieu thereof, be entitled to receive a cash payment in an amountequal to the fraction to which the stockholder would otherwise be entitledmultiplied by the average of the closing prices per share of the Common Stock,as reported in TheWallStreetJournal (as adjustedfor the reverse stock split effected hereby), during the twenty (20)consecutive trading days ending on the trading day immediately prior to the dayon which the Effective Time occurs (or if such prices are not available, theaverage of the last bid and asked prices of the Common Stock on such days (asadjusted for the reverse stock split effected hereby) or other price determinedby the Board of Directors).

 

3.             This Certificate ofAmendment has been duly adopted in accordance with Section 242 of theDelaware General Corporation Law.

 

IN WITNESSWHEREOF, the undersigned has executed this Certificate of Amendment of theAmended and Restated Certificate of Incorporation of the Corporation on this 1stday of November, 2005.

 

 
|   | /s/ Mary Beth DeLena         |   |
|--------|------------------------------|--------|
|   | Mary Beth DeLena,  Secretary |

 

----
**Exhibit 10.77**

 

**TERMINATION OF CONSULTING AGREEMENT**

 

This Termination of Consulting Agreement,dated as of June 30, 2002, is by and between Vari-Lite International, Inc. (the“Company”) and James H. Clark, Jr. (the “Consultant”).

 

# W I T N E S S E T H:

 

WHEREAS, the Company (formerly known asVari-Lite Holdings, Inc.) and the Consultant entered into that certainConsulting Agreement, dated as of July 1, 1995 (the “Consulting Agreement”);and

 

WHEREAS, the Company has suffered a declinein its financial performance and management and the Board of Directors of theCompany have made recommendations for reducing expenses of the Company in orderto improve the Company’s financial performance; and

 

WHEREAS, the Compensation Committee of theBoard of Directors of the Company (the “Compensation Committee”) has determinedthat it is in the best financial interest of the Company to terminate theConsulting Agreement effective as of June 30, 2002; and

 

WHEREAS, the Consultant is a significantstockholder of the Company and agrees that it is in the best financial interestof the Company to terminate the Consulting Agreement as proposed by theCompensation Committee;

 

NOW, THEREFORE, in consideration of theforegoing and other good and valuable consideration, the receipt andsufficiency of which are hereby acknowledged, the parties hereto hereby agree,effective as of the date hereof, that the Consulting Agreement is cancelled andterminated and shall be of no further force or effect.

 

IN WITNESS WHEREOF, the parties hereto haveexecuted this Agreement as of the date first above written.

 

 
|   | VARI-LITE  INTERNATIONAL, INC. |
|--------|--------------------------------|
|   |                           |
|   |                           |
|   | By:                            |   |
|   |                           | T. Clay  Powers, President |
|   |                           |
|   |                           |
|   | James H.  Clark, Jr.           |

 

----
Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 1 of 26 PageID #:1

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 2 of 26 PageID #:2

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 3 of 26 PageID #:3

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 4 of 26 PageID #:4

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 5 of 26 PageID #:5

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 6 of 26 PageID #:6

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 7 of 26 PageID #:7

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 8 of 26 PageID #:8

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 9 of 26 PageID #:9

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 10 of 26 PageID #:10

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 11 of 26 PageID #:11

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 12 of 26 PageID #:12

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 13 of 26 PageID #:13

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 14 of 26 PageID #:14

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 15 of 26 PageID #:15

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 16 of 26 PageID #:16

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 17 of 26 PageID #:17

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 18 of 26 PageID #:18

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 19 of 26 PageID #:19

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 20 of 26 PageID #:20

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 21 of 26 PageID #:21

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 22 of 26 PageID #:22

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 23 of 26 PageID #:23

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 24 of 26 PageID #:24

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 25 of 26 PageID #:25

Case: 1:02-cv-06608 Document #: 1 Filed: 09/17/02 Page 26 of 26 PageID #:26
<PAGE>

EXHIBIT 23.2


                          INDEPENDENT AUDITORS' CONSENT


         We consent to the incorporation by reference in the Registration
Statement on Form S-3/A, (File No. 333-81320), and the Registration Statements
on Form S-8 (File No. 333-60004 and 333-35450) of our report dated February 18,
2005 (March 9, 2005 with respect to note B[7]) relating to our audit of the
financial statements of PacificHealth Laboratories, Inc. as of December 31, 2004
and for the year ended included in this Annual Report on Form 10-KSB.


Eisner LLP

New York, NY
March 30, 2006